DOJ Indicts Startup Telehealth Executives Over ‘Easy Access’ Adderall Distribution
OTTAWA, ON, CANADA - NOVEMBER 13, 2019: Single 20 mg capsule of Adderall XR, a mixed amphetamine salts stimulant used in psychiatric medicine to treat ADD, ADHD and narcolepsy, on a gray surface.
The Department of Justice (DOJ) has arrested a startup telehealth company founder and physician for alleged distribution of Adderall and other stimulants over the internet.
These indictments mark the first charges the DOJ has filed against a telehealth company, the DOJ said.
Matt McGregor
Reporter
Matt McGregor is an Epoch Times reporter who covers general U.S. news and features.
Send him your story ideas: [email protected]
